BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19242095)

  • 21. The polycomb group protein BMI1 is a transcriptional target of HDAC inhibitors.
    Bommi PV; Dimri M; Sahasrabuddhe AA; Khandekar J; Dimri GP
    Cell Cycle; 2010 Jul; 9(13):2663-73. PubMed ID: 20543557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. JMJD3 is a histone H3K27 demethylase.
    Xiang Y; Zhu Z; Han G; Lin H; Xu L; Chen CD
    Cell Res; 2007 Oct; 17(10):850-7. PubMed ID: 17923864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. JARID1B is a histone H3 lysine 4 demethylase up-regulated in prostate cancer.
    Xiang Y; Zhu Z; Han G; Ye X; Xu B; Peng Z; Ma Y; Yu Y; Lin H; Chen AP; Chen CD
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19226-31. PubMed ID: 18048344
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ZNF217/ZFP217 Meets Chromatin and RNA.
    Lee DF; Walsh MJ; Aguiló F
    Trends Biochem Sci; 2016 Dec; 41(12):986-988. PubMed ID: 27519282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Binding of the JmjC demethylase JARID1B to LSD1/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14.
    Li Q; Shi L; Gui B; Yu W; Wang J; Zhang D; Han X; Yao Z; Shang Y
    Cancer Res; 2011 Nov; 71(21):6899-908. PubMed ID: 21937684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Breast cancer associated transcriptional repressor PLU-1/JARID1B interacts directly with histone deacetylases.
    Barrett A; Santangelo S; Tan K; Catchpole S; Roberts K; Spencer-Dene B; Hall D; Scibetta A; Burchell J; Verdin E; Freemont P; Taylor-Papadimitriou J
    Int J Cancer; 2007 Jul; 121(2):265-75. PubMed ID: 17373667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural basis for CoREST-dependent demethylation of nucleosomes by the human LSD1 histone demethylase.
    Yang M; Gocke CB; Luo X; Borek D; Tomchick DR; Machius M; Otwinowski Z; Yu H
    Mol Cell; 2006 Aug; 23(3):377-87. PubMed ID: 16885027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF-2 regulates cell proliferation, migration, and angiogenesis through an NDY1/KDM2B-miR-101-EZH2 pathway.
    Kottakis F; Polytarchou C; Foltopoulou P; Sanidas I; Kampranis SC; Tsichlis PN
    Mol Cell; 2011 Jul; 43(2):285-98. PubMed ID: 21777817
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RBP2 belongs to a family of demethylases, specific for tri-and dimethylated lysine 4 on histone 3.
    Christensen J; Agger K; Cloos PA; Pasini D; Rose S; Sennels L; Rappsilber J; Hansen KH; Salcini AE; Helin K
    Cell; 2007 Mar; 128(6):1063-76. PubMed ID: 17320161
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transcriptional repressor NIPP1 is an essential player in EZH2-mediated gene silencing.
    Nuytten M; Beke L; Van Eynde A; Ceulemans H; Beullens M; Van Hummelen P; Fuks F; Bollen M
    Oncogene; 2008 Feb; 27(10):1449-60. PubMed ID: 17724462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
    Mitra D; Das PM; Huynh FC; Jones FE
    J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histone demethylation mediated by the nuclear amine oxidase homolog LSD1.
    Shi Y; Lan F; Matson C; Mulligan P; Whetstine JR; Cole PA; Casero RA; Shi Y
    Cell; 2004 Dec; 119(7):941-53. PubMed ID: 15620353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EZH2 variants differentially regulate polycomb repressive complex 2 in histone methylation and cell differentiation.
    Mu W; Starmer J; Yee D; Magnuson T
    Epigenetics Chromatin; 2018 Dec; 11(1):71. PubMed ID: 30522506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic regulation of hematopoietic differentiation by Gfi-1 and Gfi-1b is mediated by the cofactors CoREST and LSD1.
    Saleque S; Kim J; Rooke HM; Orkin SH
    Mol Cell; 2007 Aug; 27(4):562-72. PubMed ID: 17707228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZNF198 stabilizes the LSD1-CoREST-HDAC1 complex on chromatin through its MYM-type zinc fingers.
    Gocke CB; Yu H
    PLoS One; 2008 Sep; 3(9):e3255. PubMed ID: 18806873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ndy1/KDM2B immortalizes mouse embryonic fibroblasts by repressing the Ink4a/Arf locus.
    Tzatsos A; Pfau R; Kampranis SC; Tsichlis PN
    Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2641-6. PubMed ID: 19202064
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome analysis identifies the p15ink4b tumor suppressor as a direct target of the ZNF217/CoREST complex.
    Thillainadesan G; Isovic M; Loney E; Andrews J; Tini M; Torchia J
    Mol Cell Biol; 2008 Oct; 28(19):6066-77. PubMed ID: 18625718
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The histone H3 lysine 9 methyltransferases G9a and GLP regulate polycomb repressive complex 2-mediated gene silencing.
    Mozzetta C; Pontis J; Fritsch L; Robin P; Portoso M; Proux C; Margueron R; Ait-Si-Ali S
    Mol Cell; 2014 Jan; 53(2):277-89. PubMed ID: 24389103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polycomb recruitment at the Class II transactivator gene.
    Boyd NH; Morgan JE; Greer SF
    Mol Immunol; 2015 Oct; 67(2 Pt B):482-91. PubMed ID: 26283540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
    Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
    Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.